Delenex Therapeutics
Delenex Therapeutics is engaged in developing therapeutic antibody fragments for diseases with high unmet needs.
Funding reportedLast round: Undisclosed round
What company datasets say Delenex Therapeutics raised
Funding, as reported
Reported in all41.3Min the source's currency
Rounds4
Last roundUndisclosed round
Last round dateJan 2016
Investors listed6
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Delenex Therapeutics in front of investors. Or tell us what we have wrong.